How does pheochromocytoma cause tremors?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Mechanism of Tremors in Pheochromocytoma

Pheochromocytoma causes tremors through excessive catecholamine (epinephrine and norepinephrine) secretion that directly stimulates β-adrenergic receptors, producing physiologic tremor similar to the tremulousness seen with sympathetic nervous system activation.

Pathophysiologic Mechanism

The tremors in pheochromocytoma result from catecholamine excess acting on peripheral β-adrenergic receptors in skeletal muscle. This is a direct pharmacologic effect of circulating catecholamines rather than a neurologic complication 1, 2.

Key Features of Catecholamine-Induced Tremor:

  • β-adrenergic receptor stimulation in skeletal muscle causes enhanced physiologic tremor, which is typically fine, rapid, and action-based 1, 2

  • The tremor occurs as part of the classic triad of pheochromocytoma symptoms: headaches, palpitations, and sweating, though not all patients manifest this complete triad 3, 1

  • Tremor episodes are often paroxysmal, coinciding with surges of catecholamine release from the tumor 4, 1

Clinical Context

Associated Manifestations:

  • Tachycardia and palpitations frequently accompany tremors due to β1-adrenergic cardiac stimulation 5

  • Hypertensive episodes (sustained or paroxysmal) occur in approximately 70% of pheochromocytoma cases, with paroxysmal and sustained hypertension occurring in roughly equal proportions 4

  • Pallor may be present during catecholamine surges due to peripheral vasoconstriction 4

Important Clinical Pitfall:

Not all patients with pheochromocytoma present with typical symptoms. Some patients have no classic triad and may only show abnormalities on imaging and biochemical testing, making early diagnosis challenging 3. The clinical presentation is highly variable and can mimic many other diseases 2, 6.

Management Implications

Pharmacologic Control of Tremor:

  • β-adrenergic blockade (such as propranolol 10-40 mg every 6-8 hours) effectively controls tremor, tachycardia, and arrhythmias 5

  • Critical caveat: β-blockade must never be initiated before adequate α-adrenergic blockade is established, as unopposed α-stimulation can precipitate severe hypertensive crisis 5, 7

  • The standard preoperative preparation includes α-blockade (phenoxybenzamine or doxazosin) for 1-3 weeks, followed by β-blockade only if persistent tachycardia, extrasystoles, or arrhythmias develop 5, 7

Resolution After Treatment:

  • Tremors and other catecholamine-mediated symptoms typically resolve completely after successful surgical removal of the tumor 8

  • Symptoms also improve with appropriate α-adrenergic blockade prior to surgery 8

Biochemical Basis

The continuous production of catecholamines within pheochromocytoma cells occurs via catecholamine O-methyltransferase, producing metanephrines even when exocytotic catecholamine release is episodic 9. This explains why some patients have persistent mild tremor while others experience dramatic paroxysmal episodes with severe tremulousness 1, 2.

References

Research

Phaeochromocytoma.

Lancet (London, England), 2005

Research

Progress in treatment and follow-up of pheochromocytoma.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2025

Guideline

the american association of clinical endocrinologists and american association of endocrine surgeons medical guidelines for the management of adrenal incidentalomas.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2009

Research

Pheochromocytoma: diagnosis and management update.

Current hypertension reports, 2004

Guideline

ECG Findings and Management in Pheochromocytoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.

The Journal of clinical endocrinology and metabolism, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.